Condition: Acute Respiratory Distress Syndrome · Sponsor: PT. Prodia Stem Cell Indonesia
This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.
This description comes directly from the study's public registry record.
Dewiyana Andari Kusmana · +6281290885529 · dewiyana.ku@gmail.com
Cynthia R Retna Sartika, Dr · +62811155048 · c.sartika@gmail.com
Always discuss trial participation with your own doctor first.
| RSPAD Gatot Soebroto | Jakarta Pusat, DKI Jakarta, Indonesia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07439848